Cabaletta Bio's (CABA) Buy Rating Reaffirmed at HC Wainwright
Cabaletta Bio (NASDAQ:CABA – Get Rating)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday, TipRanks reports. They presently have a $11.00 price objective on the stock. Other analysts have also issued research reports about the company. Mizuho cut their price objective on Cabaletta […]